Thyroid Hormone Transporters
Open accessThe DOI matches its Crossref record; 467 of the 477 references it cites were found in a registry or an index.
Abstract
Thyroid hormone transporters at the plasma membrane govern intracellular bioavailability of thyroid hormone. Monocarboxylate transporter (MCT) 8 and MCT10, organic anion transporting polypeptide (OATP) 1C1, and SLC17A4 are currently known as transporters displaying the highest specificity toward thyroid hormones. Structure-function studies using homology modeling and mutational screens have led to better understanding of the molecular basis of thyroid hormone transport. Mutations in MCT8 and in OATP1C1 have been associated with clinical disorders. Different animal models have provided insight into the functional role of thyroid hormone transporters, in particular MCT8. Different treatment strategies for MCT8 deficiency have been explored, of which thyroid hormone analogue therapy is currently applied in patients. Future studies may reveal the identity of as-yet-undiscovered thyroid hormone transporters. Complementary studies employing animal and human models will provide further insight into the role of transporters in health and disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Murine studies also provide strong evidence that apart from MCT8 and OATP1C1, additional TH transporters yet to be defined in humans must be active to ensure proper neural activity and a functional HPT axis (41).”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [41]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These patients carry inactivating mutations in the TH transporting MCT8 encoded by the X-linked SLC16A2 gene.”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [41]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Affected patients exhibit a severe form of psychomotor retardation in combination with an abnormal thyroid function profile (elevated T3, reduced T4 in the presence of normal-elevated TSH).”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [41]
The cited source says what the claim attributes to it.
In the citing paper
“TH transporters facilitate the transmembrane passage of TH and its metabolites and are thus mandatory for proper TH metabolism and action in every tissue (Fig. 3) (41,42).”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [41]
The cited source says what the claim attributes to it.
In the citing paper
“Interference with proper signaling is best illustrated in patients with Allan-Herndon Dudley syndrome [41].”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [41]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–467 of 467
The tricyclic antidepressant desipramine inhibits T3 import into primary neurons
Roth, S., Kinne, A., & Schweizer, U. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.04.055 · Cited by 23
Selmi-Ruby, S., Bouazza, L., Obregon, M.-J., Conscience, A., Flamant, F., Samarut, J., Borson-Chazot, F., & Rousset, B. (2014) · Endocrinology · doi:10.1210/en.2013-1435 · Cited by 23
Few Amino Acid Exchanges Expand the Substrate Spectrum of Monocarboxylate Transporter 10*
Johannes, J., Braun, D., Kinne, A., Rathmann, D., Köhrle, J., & Schweizer, U. (2016) · Molecular Endocrinology · doi:10.1210/me.2016-1037 · Cited by 23
MCT8 is downregulated by short time iodine overload in the thyroid gland of rats
de Souza, E., Dias, G., Cardoso, R., Lima, L., Fortunato, R., Visser, T., Vaisman, M., Ferreira, A., & Carvalho, D. (2015) · Hormone and Metabolic Research · doi:10.1055/s-0035-1550008 · Cited by 23
Badziong, J., Ting, S. C., Synoracki, S., Tiedje, V., Brix, K., Brabant, G. E., Moeller, L. C., Schmid, K. W., Führer, D., & Zwanziger, D. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0279 · Cited by 23
Isolation and chromosomal mapping of a novel human gene showing homology to Na+/PO4 cotransporter
Shibui, A., Tsunoda, T., Seki, N., Suzuki, Y., Sugane, K., & Sugano, S. (1999) · Journal of Human Genetics · doi:10.1007/s100380050140 · Cited by 22
Bassi, M. T., Sperandeo, M. P., Incerti, B., Bulfone, A., Pepe, A., Surace, E. M., Gattuso, C., Grandi, A. D., Buoninconti, A., Riboni, M., et al. (1999) · Genomics · doi:10.1006/geno.1999.5978 · Cited by 22
Rodrigues, T. B., Ceballos, A., Grijota-Martínez, C., Núñez, B., Refetoff, S., Cerdán, S., Morte, B., & Bernal, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074621 · Cited by 22
Kinne, A., Wittner, M., Wirth, E. K., Hinz, K. M., Schülein, R., Köhrle, J., & Krause, G. (2015) · European Thyroid Journal · doi:10.1159/000381542 · Cited by 22
Sorafenib-Induced Changes in Thyroid Hormone Levels in Patients Treated for Hepatocellular Carcinoma
Beukhof, C. M., van Doorn, L., Visser, T. J., Bins, S., Visser, W. E., van Heerebeek, R., van Kemenade, F. J., de Rijke, Y. B., de Herder, W. W., Chaker, L., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-4025 · Cited by 22
Self-citationUemura, S., Mochizuki, T., Kurosaka, G., Hashimoto, T., Masukawa, Y., & Abe, F. (2017) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2017.07.013 · Cited by 22
Structural Insights Into Thyroid Hormone Transport Mechanisms of the L-Type Amino Acid Transporter 2
Hinz, K. M., Meyer, K., Kinne, A., Schülein, R., Köhrle, J., & Krause, G. (2015) · Molecular Endocrinology · doi:10.1210/me.2015-1044 · Cited by 21
Elevated TSH levels in a mentally retarded boy
Crushell, E., & Reardon, W. (2009) · European Journal of Pediatrics · doi:10.1007/s00431-009-1075-0 · Cited by 21
Membrane-traversing mechanism of thyroid hormone transport by monocarboxylate transporter 8
Protze, J., Braun, D., Hinz, K. M., Bayer-Kusch, D., Schweizer, U., & Krause, G. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2461-9 · Cited by 21
Kim, J. H., Kim, Y., Yum, M., Choi, J., Lee, B. H., Kim, G.-H., & Yoo, H. (2015) · Hormone Research in Paediatrics · doi:10.1159/000371466 · Cited by 20
Hypotonic male infant and MCT8 deficiency - a diagnosis to think about
Rodrigues, F., Grenha, J., Ortez, C., Nascimento, A., Morte, B., Belinchón, M. M., Armstrong, J., & Colomer, J. (2014) · BMC Pediatrics · doi:10.1186/1471-2431-14-252 · Cited by 20
Groeneweg, S., van den Berge, A., Meima, M. E., Peeters, R. P., Visser, T. J., & Visser, W. E. (2018) · Endocrinology · doi:10.1210/en.2017-00846 · Cited by 20
Self-citationVisser, W. E., van Mullem, A. A., Jansen, J., & Visser, T. J. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.02.003 · Cited by 19
Self-citationStuart, R. O., Pavlova, A. V., Beier, D. R., Li, Z., Krijanovski, Y., & Nigám, S. K. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.281.6.f1148 · Cited by 19
Ono, E., Ariga, M., Oshima, S., Hayakawa, M., Imai, M., Ochiai, Y., Mochizuki, H., Namba, N., Ozono, K., & Miyata, I. (2016) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.25.23 · Cited by 19
In Vitro Characterization of Human, Mouse, and Zebrafish MCT8 Orthologues
Groeneweg, S., Kersseboom, S., van den Berge, A., Dolcetta‐Capuzzo, A., van Geest, F. S., van Heerebeek, R. E. A., Arjona, F. J., Meima, M. E., Peeters, R. P., Visser, W. E., et al. (2019) · Thyroid · doi:10.1089/thy.2019.0009 · Cited by 19
Self-citationHuman LAT1 single nucleotide polymorphism N230K does not alter phenylalanine transport
Boado, R. J., Li, J. Y., Wise, P. M., & Pardridge, W. M. (2004) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2004.07.008 · Cited by 18
Modulation of monocarboxylate transporter 8 oligomerization by specific pathogenic mutations
Fischer, J., Kleinau, G., Müller, A., Kühnen, P., Zwanziger, D., Kinne, A., Rehders, M., Moeller, L. C., Führer, D., Grüters, A., et al. (2015) · Journal of Molecular Endocrinology · doi:10.1530/jme-14-0272 · Cited by 18
Hong, W., Wu, Z., Fang, Z., Huang, J., Huang, H., & Hong, M. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00466 · Cited by 18
Kersseboom, S., van Gucht, A. L. M., van Mullem, A. A., Brigante, G., Farina, S., Carlsson, B., Donkers, J. M., van de Graaf, S. F. J., Peeters, R. P., & Visser, T. J. (2017) · Endocrinology · doi:10.1210/en.2017-00433 · Cited by 18
Self-citationFischer, J., Kleinau, G., Rutz, C., Zwanziger, D., Khajavi, N., Müller, A., Rehders, M., Brix, K., Worth, C. L., Führer, D., et al. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2728-1 · Cited by 18
Tan, H.-J., Deng, M., Qiu, J., Wu, J.-F., & Song, Y. (2018) · Frontiers in Pediatrics · doi:10.3389/fped.2018.00354 · Cited by 18
Ontogeny and plasma-membrane domain localization of amino acid transport system L in rat liver
Novak, D., Kilberg, M. S., & Beveridge, M. J. (1994) · Biochemical Journal · doi:10.1042/bj3010671 · Cited by 17
Wirth, E. K., Rijntjes, E., Meyer, F. I., Köhrle, J., & Schweizer, U. (2015) · European Thyroid Journal · doi:10.1159/000381021 · Cited by 17
Lago‐Lestón, R., Iglesias, M., San‐José, E., Areal, C., Eiras, A., Araújo‐Vilar, D., Lado‐Abeal, J., & Domínguez‐Gerpe, L. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03377.x · Cited by 17
Functional Characterization of Xenopus Thyroid Hormone Transporters mct8 and oatp1c1
Mughal, B. B., Leemans, M., de Souza, E. C. L., Mével, S. L., Špirhanzlová, P., Visser, T. J., Fini, J., & DEMENEIX, B. A. (2017) · Endocrinology · doi:10.1210/en.2017-00108 · Cited by 17
An Essential Physiological Role for MCT8 in Bone in Male Mice
Leitch, V. D., Cosmo, C. D., Liao, X.-H., O'Boy, S., Galliford, T. M., Evans, H., Croucher, P. I., BOYDE, A., Dumitrescu, A. M., Weiss, R. E., et al. (2017) · Endocrinology · doi:10.1210/en.2017-00399 · Cited by 17
Importance of Cysteine Residues in the Thyroid Hormone Transporter MCT8
de Souza, E. C. L., Groeneweg, S., Visser, W. E., Peeters, R. P., & Visser, T. J. (2013) · Endocrinology · doi:10.1210/en.2012-2101 · Cited by 16
Self-citationUnderstanding the Hypothalamus-Pituitary-Thyroid Axis in Mct8 Deficiency
Müller, J., & Heuer, H. (2012) · European Thyroid Journal · doi:10.1159/000339474 · Cited by 16
Self-citationTriiodothyroacetic Acid Treatment in MCT8 Deficiency: A Word of Nuance
Visser, W. E., Heuer, H., & Visser, T. J. (2016) · Thyroid · doi:10.1089/thy.2016.0191 · Cited by 16
Self-citationNovel SLC16A2 mutations in patients with Allan-Herndon-Dudley syndrome
Shimojima, K. Y., Maruyama, K., Kikuchi, M., Imai, A., Inoue, K., & Yamamoto, T. (2016) · Intractable & Rare Diseases Research · doi:10.5582/irdr.2016.01051 · Cited by 16
Hinz, K. M., Neef, D., Rutz, C., Furkert, J., Köhrle, J., Schülein, R., & Krause, G. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.01.024 · Cited by 16
Kobayashi, S., Onuma, A., Inui, T., Wakusawa, K., Tanaka, S., Shimojima, K. Y., Yamamoto, T., & Haginoya, K. (2014) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2014.05.004 · Cited by 15
Stohn, J. P., Martinez, M. E., Matoin, K. L., Morte, B., Bernal, J., Galton, V. A., Germain, D. L. S., & Hernández, A. (2016) · Endocrinology · doi:10.1210/en.2016-1162 · Cited by 15
Islam, M. S., Namba, N., Ohata, Y., Fujiwara, M., Nakano, C., Takeyari, S., Miyata, K., Nakano, Y., Yamamoto, K., Nakayama, H., et al. (2018) · Endocrine Journal · doi:10.1507/endocrj.ej18-0251 · Cited by 15
Choi, J., Cho, J. H., Kim, J. H., Yoo, E.-G., Kim, G.-H., & Yoo, H. (2018) · Hormone Research in Paediatrics · doi:10.1159/000493468 · Cited by 15
Allan–Herndon–Dudley syndrome with unusual profound sensorineural hearing loss
Gagliardi, L., Nataren, N. J., Feng, J., SCHREIBER, A. W., Hahn, C. N., Conwell, L. S., Coman, D. J., & Scott, H. S. (2015) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37075 · Cited by 14
Iodine deficiency up-regulates monocarboxylate transporter 8 expression of mouse thyroid gland
Hu, Z., Zhuo, X., Shi, Y., Liu, X., Yuan, J., Li, L., & Sun, Y. (2014) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20141314 · Cited by 13
Rego, T., Gómez‐Lado, C., Cabanas, P., Santos, F. S., Barros, F., Castro-Feijóo, L., Conde, J. B., & Gago, M. C. (2017) · HORMONES · doi:10.14310/horm.2002.1733 · Cited by 13
Is the Kidney a Major Storage Site for Thyroxine as Thyroxine Glucuronide?
Buitendijk, M., & Galton, V. A. (2012) · Thyroid · doi:10.1089/thy.2011.0307 · Cited by 12
Zwanziger, D., Schmidt, M., Fischer, J., Kleinau, G., Braun, D., Schweizer, U., Moeller, L. C., Biebermann, H., & Fuehrer, D. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.05.017 · Cited by 12
SLC16A2 mutations in two Japanese patients with Allan–Herndon–Dudley syndrome
Yamamoto, T., Shimojima, K. Y., Umemura, A., Uematsu, M., Nakayama, T., & Inoue, K. (2014) · Human Genome Variation · doi:10.1038/hgv.2014.10 · Cited by 11
Bian, J., Jin, M., Yue, M., Wang, M., Zhang, H., & Gui, C. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00648 · Cited by 11
Brožaitienė, J., Skiriutė, D., Burkauskas, J., Podlipskytė, A., Jankauskienė, E., Serretti, A., & Mickuvienė, N. (2018) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2017.0283 · Cited by 11
Authentic Bosutinib Inhibits Triiodothyronine Transport by Monocarboxylate Transporter 8
Braun, D., & Schweizer, U. (2014) · Thyroid · doi:10.1089/thy.2013.0660 · Cited by 10
Age-Dependent Changes of Monocarboxylate Transporter 8 Availability in the Postnatal Murine Retina
Henning, Y., & Szafranski, K. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00205 · Cited by 10
Fang, Z., Huang, J., Chen, J., Xu, S., Xiang, Z., & Hong, M. (2018) · Molecular Pharmacology · doi:10.1124/mol.118.111914 · Cited by 10
Teresa, B. G., Angel, A. G., Reyna‐Fabián, M. E., Ruiz-Reyes, M. D. L. L., Calzada-León, R., Pérez-Enríquez, B., & Alcántara‐Ortigoza, M. A. (2014) · Thyroid · doi:10.1089/thy.2014.0284 · Cited by 9
Zorick, T. S., Kleimann, S., Sertie, A. L., Zatz, M., Rosenberg, S., & Passos‐Bueno, M. R. (2004) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30009 · Cited by 9
A 7‐month‐old male with Allan‐Herndon‐Dudley syndrome and the power of T3
Langley, K. G., Trau, S. P., Bean, L. J., Narravula, A., & Vergano, S. A. S. (2015) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36970 · Cited by 8
Yamamoto, S., Okuhara, K., Tonoki, H., Iizuka, S., Nihei, N., & Tajima, T. (2013) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.22.83 · Cited by 8
Alvarez‐Salas, E., Mengod, G., García-Luna, C., Soberanes-Chávez, P., Matamoros‐Trejo, G., & de Gortari, P. (2015) · Neuropeptides · doi:10.1016/j.npep.2015.11.001 · Cited by 8
[Clinical and genetic features of five patients with Allan-Herndon-Dudley syndrome].
Wang, J., Zhang, Q., Bao, X., Chen, Y., & Yu, S. (2018) · PubMed · doi:10.3760/cma.j.issn.1003-9406.2018.04.005 · Cited by 7
Marín, L. L., Belinchón, M. M., Gutiérrez-Solana, L. G., Molina, B. M., Rodríguez, A. D., & Carrasco, J. B. (2013) · Revista de Neurología · doi:10.33588/rn.5612.2012617 · Cited by 5
Intermittent Esotropia in 4 Patients With Allan-Herndon-Dudley Syndrome
Swiston, C. J., & Nash, D. L. (2018) · Journal of Child Neurology · doi:10.1177/0883073818770597 · Cited by 5
[A family with Allan-Herndon-Dudley syndrome due to SLC16A2 gene mutation].
Tang, Y.-G., Peng, J., Xiong, J., Pang, N., Wu, L., Yang, H., Kessi, M., & Yin, F. (2018) · PubMed · doi:10.3760/cma.j.issn.0578-1310.2018.11.008 · Cited by 5
Goto, M., Ito, K., Okamoto, N., Sato, N., & Sasaki, M. (2012) · Clinical Nuclear Medicine · doi:10.1097/rlu.0b013e31827082d8 · Cited by 4
Bedoyan, J. K., Tim‐Aroon, T., Deeb, K. K., Ganganna, S. T., & Bass, N. E. (2015) · Clinical Pediatrics · doi:10.1177/0009922815584219 · Cited by 4
Yamamoto, T., Takanashi, J., Kurosawa, K., Deguchi, K., Osaka, H., & Inoue, K. (2015) · Brain and Development · doi:10.1016/j.braindev.2015.03.007 · Cited by 3
Effect of tryptophan on the early tri-iodothyronine uptake in mouse thymocytes
Centanni, M., Canettieri, G., Viceconti, N., Sibilla, R., Bei, A., & Andreoli, M. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1430119 · Cited by 3
Novel A178P mutation in SLC16A2 in a patient with Allan‐Herndon‐Dudley syndrome
Yamamoto, T., Lu, Y.-P., Nakamura, R., Shimojima, K. Y., & Kira, R. (2017) · Congenital Anomalies · doi:10.1111/cga.12251 · Cited by 3
Localization of the System L Amino Acid Transporters LAT1 and LAT2 in Rat Gastrointestinal Tract
Kobayashi, Y. (2007) · 杏林医学会雑誌 · doi:10.11434/kyorinmed.38.75 · Cited by 2
Research works printed but not linked: 14
- Allan, 1944, Some examples of the inheritance of mental deficiency: apparently sex-linked idiocy and microcephaly, Am J Ment Defic., 48, 325
- Davis, 1981, A new X-linked recessive mental retardation syndrome with progressive spastic quadriparesis, Am J Hum Genet., 33, 75A
- Raymond, 2008, Raised T3 levels and mutations in MCT8 (SLC16A2) cause X-linked cerebral palsy and mental retardation, Eur J Med Genet., 14, 60
- Dateki, 2013, A novel MCT8 mutation in a Japanese patient with Allan-Herndon-Dudley syndrome, Horm Res., 80, 360
- Wood, 2008, The utilization of T3/T4 screening of males with MR of unknown etiology to identify patients with Allan-Herndon-Dudley syndrome, Eur J Hum Genet., 16, 26
- Iglesias Álvarez, 2015, Respuesta hormonal al tratamiento con triac en 5 niños españoles con síndrome de allan-herndon-dudley por defecto en el transportador mct8 de hormonas tiroideas, Rev Esp Endocrinol Pediatr., 6, 91
- Noguchi, 2009, Transient acidosis in infancy with a novel variant in MCT8 (Monocarboxylate transporter 8) gene, Horm Res., 72, 310
- Fu, 2014, OR29-3: whole-exome sequencing identified a novel MCT8 gene mutation in a child with mild cognitive, motor and behavior abnormalities, OR29
- Faruk Aydin, 2013, Allan-Herndon-Dudley syndrome caused by a novel MCT8/SLC16A2 mutation in a Turkish family, Horm Res., 80, 352
- Ugrasbul, 2009, A patient presenting with central hypothyroidism, developmental delay and poor head control. Should we be checking T3 levels?, Horm Res, 72, 458
- Tasdelen, 2016, A novel mutation in SLC16A2 gene in a Turkish boy with Allan-Herndon-Dudley Syndrome, Eur J Hum Genet., 24, P10.01A
- López-Marín, 2013, MCT8-specific thyroid hormone cell transporter deficiency: a case report and review of the literature, Rev Neurol., 56, 615
- Groeneweg, 2019, Effectiveness and safety of Triac in children and adults with MCT8 deficiency: an international, multicentre, single group, open-label, phase 2 trial, Lancet Diabetes Endocrinol., 7, 695, 10.1016/s2213-8587(19)30155-x · DOI · Paper page
- Filho, 2011, Novel mutation in MCT8 gene in a Brazilian boy with thyroid hormone resistance and severe neurologic abnormalities, Arq Bras Endocrinol Metabol., 55, 60, 10.1590/s0004-27302011000100008 · DOI · Paper page
Cited by
The Role of the Thyroid Axis in Fish
Deal, C. K., & Volkoff, H. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.596585 · Cited by 241
Jonklaas, J., Bianco, A. C., Cappola, A. R., Celi, F. S., Fliers, E., Heuer, H., McAninch, E. A., Moeller, L. C., Nygaard, B., Sawka, A. M., et al. (2021) · Thyroid® · doi:10.1089/thy.2020.0720 · Cited by 172
Self-citationWenzek, C., Boelen, A., Westendorf, A. M., Engel, D. R., Moeller, L. C., & Führer-Sakel, D. (2022) · European Journal of Endocrinology · doi:10.1530/eje-21-1171 · Cited by 136
Metabolic Messengers: Thyroid Hormones
Sinha, R. A., & Yen, P. M. (2024) · Nature Metabolism · doi:10.1038/s42255-024-00986-0 · Cited by 134
Groeneweg, S., van Geest, F. S., Abacı, A., Alcantud, A., Ambegaonkar, G., Armour, C. M., Bakhtiani, P., Bârcă, D., Bertini, E., van Beynum, I. M., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30153-4 · Cited by 122
Self-citation
Metadata
- Authors
- Groeneweg, S., van Geest, F. S., Peeters, R. P., Heuer, H., & Visser, W. E.
- Affiliations
- Erasmus MC (NL)
- Department of Internal Medicine, Erasmus Medical Center, Rotterdam, the Netherlands Academic Center for Thyroid Diseases, Erasmus Medical Center, Rotterdam, the Netherlands
- Essen University Hospital (DE)
- Corresponding author
- Visser, W Edward
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2019-11-22
- Volume
- 41
- Issue
- 2
- Pages
- 146-201
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2989561443
- Cited by
- 216
- References
- 477
- Citations by year
- 2026: 30 · 2025: 34 · 2024: 40 · 2023: 31 · 2022: 36 · 2021: 31 · 2020: 14
- FWCI
- 3.12
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- Funders
- Sherman family
- Eurostars
- Deutsche Forschungsgemeinschaft (SPP1629)
- Federal Ministry of Education and Research
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Chemical Analysis and Environmental Impact
- Keywords
- thyroid hormone transporters, MCT8, MCT10, OATP1C1, MCT8 deficiency, transporter structure and function
- MeSH terms
- Animals, Biological Transport, Humans, Muscle Hypotonia, Muscular Atrophy, Thyroid Hormones, Membrane Transport Proteins, Organic Anion Transporters, Monocarboxylic Acid Transporters, Symporters, X-Linked Intellectual Disability, Mental Retardation, X-Linked
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.